FG-3019

• Description :

  FG-3019 (Pamrevlumab) is a recombinant human antibody that binds to connective tissue growth factor (CTGF) . FG-3019 can be used for the research of idiopathic pulmonary fibrosis (IPF) [1][2].

• Product Name Alternative :

  Pamrevlumab; Anti-Human CTGF Recombinant Antibody

• UNSPSC :

  12352203

• Target :

  Apoptosis

• Type :

  Inhibitory Antibodies

• Related Pathways :

  Apoptosis

• Applications :

  Cancer-programmed cell death

• Field of Research :

  Cancer

• Assay Protocol :

  https://www.medchemexpress.com/fg-3019.html

• Purity :

  99.00

• Solubility :

  H2O

• Smiles :

  [FG-3019]

• Molecular Weight :

  (144.86 kDa)

• References & Citations :

  [1]Sgalla G, et, al. Pamrevlumab for the treatment of idiopathic pulmonary fibrosis. Expert Opin Investig Drugs. 2020 Aug;29 (8) :771-777.|[2]Neesse A, et, al. CTGF antagonism with mAb FG-3019 enhances chemotherapy response without increasing drug delivery in murine ductal pancreas cancer. Proc Natl Acad Sci U S A. 2013 Jul 23;110 (30) :12325-30.

• Shipping Conditions :

  Dry Ice

• Storage Conditions :

  Store at -80°C for 2 years

• Scientific Category :

  Inhibitory Antibodies

• Clinical Information :

  Phase 3

• CAS Number :

  [946415-13-0]